by Brad Power, Process Innovator and Cancer Treatment Re-engineer; diagnosed with lymphoma in July of 2018 Summary: The potential of next-generation sequencing to revolutionize cancer treatment by enabling personalized therapies is still more promise than reality. Despite the best intentions ... Continue reading →